LivaNova (LIVN) Enterprise Value (2014 - 2026)
LivaNova (LIVN) reported Enterprise Value of -$539.7 million for Q1 2026, up 26.91% on a YoY basis from -$425.3 million in Q1 2025, and up 15.08% sequentially from -$635.6 million in Q4 2025.
LivaNova (LIVN) Enterprise Value (2014 - 2026) Analysis & Trends
LivaNova (LIVN) has 13 years of Enterprise Value data on file, last reported at -$539.7 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 26.91% year-over-year to -$539.7 million; the trailing twelve-month figure through Mar 2026 stood at -$539.7 million (up 26.91% YoY), and the FY2025 full-year result was -$635.6 million, down 48.2% from the prior year.
- Enterprise Value rose to -$539.7 million in Q1 2026, from -$635.6 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$276.0 million in Q3 2022 to a low of -$738.4 million in Q1 2025.
- A 5-year average of -$381.5 million and a median of -$311.4 million in 2023 frame the typical range for Enterprise Value.
- Peak annual rise in Enterprise Value reached 30.93% in 2022, while the deepest fall reached 183.96% in 2022.
- Tracing LIVN's Enterprise Value over 5 years: stood at -$302.8 million in 2022, then retreated by 2.84% to -$311.4 million in 2023, then sank by 37.73% to -$428.9 million in 2024, then slumped by 48.2% to -$635.6 million in 2025, then gained by 15.08% to -$539.7 million in 2026.
- Business Quant data shows LIVN's Enterprise Value at -$539.7 million in Q1 2026, -$635.6 million in Q4 2025, and -$738.4 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.66 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -2.88 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -8.61 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -1.21 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -3.67 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -1.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -3.09 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.07 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | -577.00 Mn |
| 10 | LivaNova | 4.30 Bn | 3.76 Bn | 243.75 Mn | -539.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -539.71 Mn |
| Dec 31, 2025 | -635.55 Mn |
| Mar 31, 2025 | -738.44 Mn |
| Dec 31, 2024 | -428.86 Mn |
| Sep 30, 2024 | -346.37 Mn |
| Jun 30, 2024 | -303.88 Mn |
| Mar 31, 2024 | -306.50 Mn |
| Dec 31, 2023 | -311.37 Mn |
| Sep 30, 2023 | -298.80 Mn |
| Jun 30, 2023 | -311.43 Mn |
| Mar 31, 2023 | -308.60 Mn |
| Dec 31, 2022 | -302.78 Mn |
| Sep 30, 2022 | -275.96 Mn |
| Jun 30, 2022 | -300.27 Mn |
| Mar 31, 2022 | -313.68 Mn |
| Dec 31, 2021 | -106.63 Mn |
| Sep 30, 2021 | -277.77 Mn |
| Jun 30, 2021 | -434.76 Mn |
| Mar 31, 2021 | -252.54 Mn |
| Dec 31, 2020 | -254.89 Mn |